These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32235863)

  • 61. Exploring electrostatic interactions of relaxin family peptide receptor 3 and 4 with ligands using a NanoBiT-based binding assay.
    Wang JH; Nie WH; Shao XX; Li HZ; Hu MJ; Liu YL; Xu ZG; Guo ZY
    Biochim Biophys Acta Biomembr; 2019 Apr; 1861(4):776-786. PubMed ID: 30684458
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Design and recombinant expression of insulin-like peptide 5 precursors and the preparation of mature human INSL5.
    Luo X; Bathgate RA; Zhang WJ; Liu YL; Shao XX; Wade JD; Guo ZY
    Amino Acids; 2010 Nov; 39(5):1343-52. PubMed ID: 20383778
    [TBL] [Abstract][Full Text] [Related]  

  • 63. GAIN domain-mediated cleavage is required for activation of G protein-coupled receptor 56 (GPR56) by its natural ligands and a small-molecule agonist.
    Zhu B; Luo R; Jin P; Li T; Oak HC; Giera S; Monk KR; Lak P; Shoichet BK; Piao X
    J Biol Chem; 2019 Dec; 294(50):19246-19254. PubMed ID: 31628191
    [TBL] [Abstract][Full Text] [Related]  

  • 64. G-protein-coupled receptor (GPCR)-142 does not contribute to relaxin-3 binding in the mouse brain: further support that relaxin-3 is the physiological ligand for GPCR135.
    Sutton SW; Bonaventure P; Kuei C; Nepomuceno D; Wu J; Zhu J; Lovenberg TW; Liu C
    Neuroendocrinology; 2005; 82(3-4):139-50. PubMed ID: 16679775
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Dihydromunduletone Is a Small-Molecule Selective Adhesion G Protein-Coupled Receptor Antagonist.
    Stoveken HM; Bahr LL; Anders MW; Wojtovich AP; Smrcka AV; Tall GG
    Mol Pharmacol; 2016 Sep; 90(3):214-24. PubMed ID: 27338081
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Partial agonist activity of R3(BΔ23-27)R/I5 at RXFP3--investigation of in vivo and in vitro pharmacology.
    Kristensson L; Mayer G; Ploj K; Wetterlund M; Arlbrandt S; Björquist A; Wissing BM; Castaldo M; Larsson N
    Eur J Pharmacol; 2015 Jan; 747():123-31. PubMed ID: 25496752
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Gedunin- and Khivorin-Derivatives Are Small-Molecule Partial Agonists for Adhesion G Protein-Coupled Receptors GPR56/ADGRG1 and GPR114/ADGRG5.
    Stoveken HM; Larsen SD; Smrcka AV; Tall GG
    Mol Pharmacol; 2018 May; 93(5):477-488. PubMed ID: 29476042
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Functionality of an absolutely conserved glycine residue in the chimeric relaxin family peptide R3/I5.
    Wang JH; Shao XX; Hu MJ; Liu YL; Xu ZG; Guo ZY
    Amino Acids; 2019 Apr; 51(4):619-626. PubMed ID: 30604098
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Site-specific DOTA/europium-labeling of recombinant human relaxin-3 for receptor-ligand interaction studies.
    Zhang WJ; Luo X; Liu YL; Shao XX; Wade JD; Bathgate RA; Guo ZY
    Amino Acids; 2012 Aug; 43(2):983-92. PubMed ID: 22187146
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Human Insulin-like Peptide 5 (INSL5). Identification of a Simplified Version of Two-Chain Analog A13.
    Zhang X; Bathgate RAD; Hossain MA
    ACS Med Chem Lett; 2020 Dec; 11(12):2455-2460. PubMed ID: 33335667
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The relaxin family peptide receptor 3 activates extracellular signal-regulated kinase 1/2 through a protein kinase C-dependent mechanism.
    van der Westhuizen ET; Werry TD; Sexton PM; Summers RJ
    Mol Pharmacol; 2007 Jun; 71(6):1618-29. PubMed ID: 17351017
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The structural and functional role of the B-chain C-terminal arginine in the relaxin-3 peptide antagonist, R3(BDelta23-27)R/I5.
    Hossain MA; Bathgate RA; Rosengren KJ; Shabanpoor F; Zhang S; Lin F; Tregear GW; Wade JD
    Chem Biol Drug Des; 2009 Jan; 73(1):46-52. PubMed ID: 19152634
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Rapid preparation of bioluminescent tracers for relaxin family peptides using sortase-catalysed ligation.
    Wang JH; Shao XX; Hu MJ; Wei D; Nie WH; Liu YL; Xu ZG; Guo ZY
    Amino Acids; 2017 Sep; 49(9):1611-1617. PubMed ID: 28631012
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Structure and activity in the relaxin family of peptides.
    Tregear GW; Bathgate RA; Hossain MA; Lin F; Zhang S; Shabanpoor F; Scott DJ; Ma S; Gundlach AL; Samuel CS; Wade JD
    Ann N Y Acad Sci; 2009 Apr; 1160():5-10. PubMed ID: 19416150
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Identification of Novel, Structurally Diverse, Small Molecule Modulators of GPR119.
    Nieto A; Fernández-Vega V; Spicer TP; Sturchler E; Adhikari P; Kennedy N; Mandat S; Chase P; Scampavia L; Bannister T; Hodder P; McDonald PH
    Assay Drug Dev Technol; 2018 Jul; 16(5):278-288. PubMed ID: 30019946
    [TBL] [Abstract][Full Text] [Related]  

  • 76. International Union of Pharmacology LVII: recommendations for the nomenclature of receptors for relaxin family peptides.
    Bathgate RA; Ivell R; Sanborn BM; Sherwood OD; Summers RJ
    Pharmacol Rev; 2006 Mar; 58(1):7-31. PubMed ID: 16507880
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Delineation of the GPRC6A receptor signaling pathways using a mammalian cell line stably expressing the receptor.
    Jacobsen SE; Nørskov-Lauritsen L; Thomsen AR; Smajilovic S; Wellendorph P; Larsson NH; Lehmann A; Bhatia VK; Bräuner-Osborne H
    J Pharmacol Exp Ther; 2013 Nov; 347(2):298-309. PubMed ID: 24008333
    [TBL] [Abstract][Full Text] [Related]  

  • 78. R3(BDelta23 27)R/I5 chimeric peptide, a selective antagonist for GPCR135 and GPCR142 over relaxin receptor LGR7: in vitro and in vivo characterization.
    Kuei C; Sutton S; Bonaventure P; Pudiak C; Shelton J; Zhu J; Nepomuceno D; Wu J; Chen J; Kamme F; Seierstad M; Hack MD; Bathgate RA; Hossain MA; Wade JD; Atack J; Lovenberg TW; Liu C
    J Biol Chem; 2007 Aug; 282(35):25425-35. PubMed ID: 17606621
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Identification of a novel small-molecule agonist for human G protein-coupled receptor 3.
    Ye C; Zhang Z; Wang Z; Hua Q; Zhang R; Xie X
    J Pharmacol Exp Ther; 2014 Jun; 349(3):437-43. PubMed ID: 24633425
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Structural commonality of C1q TNF-related proteins and their potential to activate relaxin/insulin-like family peptide receptor 1 signalling pathways in cancer cells.
    Klonisch T; Glogowska A; Thanasupawat T; Burg M; Krcek J; Pitz M; Jaggupilli A; Chelikani P; Wong GW; Hombach-Klonisch S
    Br J Pharmacol; 2017 May; 174(10):1025-1033. PubMed ID: 27443788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.